Research

ISCI Research

Basic Cell Biology, Blood, Bone & Skin, Cancer, Cardiovascular, Diabetes and Nervous System.

Clinical Trials

Clinical Trials

Phase I/II clinical trials testing mesenchymal stem cells (MSC) in cardiology and wound care.

Leadership

ISCI Leadership

Renowned physician-scientists set a vision for the future of regenerative medicine.

Latest News

Artificial Embryos Made from Stem Cells Raise Ethical Issues

Stem cells (so-called “master cells”) are unique and important in the body because they can do almost anything, and scientists have only begun to discover their potential. That’s why researchers’ use of them has created controversy, attracting the attention of scientists, policymakers, and bioethicists across the globe. Stem cells can transform into any of the body’s more than 200 cell types.

Read more on the Miller School Web site »

Sylvester Researchers Show Nitric Oxide Suppresses Drug-Resistant Prostate Cancer

Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have shown in animal models that S-nitrosoglutathione (GSNO), a compound that increases nitric oxide (NO) levels, suppresses castration-resistant prostate cancer and has a major impact on tumor microenvironments. The discovery could lead to new therapies for prostate cancer patients with few options.

Read more on the Miller School Web site »

Miller School Researcher Receives $1.5 Million Grant to Study Role of Osteopontin in Heart Failure

A Miller School of Medicine researcher has received a $1.5 million grant from the National Heart, Lung and Blood Institute to study a potential new strategy for treating an intractable form of heart failure. “Prior studies have shown that lowering the level of a protein called osteopontin can ameliorate heart failure with reduced ejection fraction,” said Lina Shehadeh, Ph.D., assistant professor of medicine.

Read more on the Miller School Web site »